Long-term Study of Ciclosporin for Atopic Dermatitis
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
In patients with severe adult atopic dermatitis, the safety and efficacy of OL27-400MEPC will
be assessed by repeating oral administration at a dose of 3 mg/kg/day (2-5 mg/kg/day) in 2
divided doses daily for 8-12 weeks and recovery until 52 weeks after starting treatment